Spectrum of Alport syndrome in an Indian cohort
Pediatric Nephrology · 2025-02 · 40 (2) · 393-405
DOI: 10.1007/s00467-024-06507-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Nephrology, online erschienen am 16.09.2024. Verfasst von Menka Yadav und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, ICMR Center for Advanced Research in Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Na…. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Collagen Type IV. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Government of India.
Abstract (Originalsprache)
BACKGROUND: Next-generation sequencing has enabled non-invasive diagnosis of type IV collagen disease in clinical settings other than the typical presentation of Alport syndrome (AS). METHODS: We reviewed the clinical and histological records of children diagnosed with Alport syndrome based on next-generation sequencing. Variants on clinical exome sequencing were categorized using ACMG 2015 criteria. RESULTS: During 2015-2023, we found 43 patients (34 boys) with 39 variants in COL4A5 (n = 27), COL4A4 (n = 7), and COL4A3 (n = 5). Thirty, 8, and 5 patients had X-linked, autosomal recessive, and autosomal dominant disease, respectively. The median (IQR) age and eGFR at diagnosis were 10 (7-13) years and 100.1 (59-140) ml/min/1.73 m2, respectively. Fifteen patients were initially diagnosed with steroid-resistant nephrotic syndrome. Alport syndrome was suspected in these patients due to persistent microscopic hematuria, eGFR 30 ml/min/1.73 m2 was 15.6 (13-18) years. CONCLUSIONS: The phenotype of Alport syndrome varies from asymptomatic urinary abnormalities to hematuria, proteinuria and/or low eGFR, and steroid-resistant nephrotic syndrome. Adverse outcomes are common, especially in boys with X-linked disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, ICMR Center for Advanced Research in Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
- MedGenome Laboratories, Bangalore, India.
- Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology, Delhi, India.
- Division of Nephrology, ICMR Center for Advanced Research in Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. aditisinhaaiims@gmail.com.
Förderung
- Indian Council of Medical Research
- Department of Biotechnology, Government of India
Zitieren
APA
Yadav, M., Jadon, T., Singh, G., Devi, K. G., Chandan, M., Khandelwal, P., Meena, J., Geetha, T. S., Faruq, M., Hari, P., Sinha, A., & Bagga, A. (2025). Spectrum of Alport syndrome in an Indian cohort. Pediatric Nephrology, 40(2), 393-405. https://doi.org/10.1007/s00467-024-06507-1
Vancouver
Yadav M, Jadon T, Singh G, Devi KG, Chandan M, Khandelwal P, et al. Spectrum of Alport syndrome in an Indian cohort. Pediatric Nephrology. 2025;40(2):393-405. doi:10.1007/s00467-024-06507-1
BibTeX
@article{Yadav2025,
author = {Yadav, Menka and Jadon, Trishla and Singh, Geetika and Devi, Kshetrimayum Ghanapriya and Chandan, Monica and Khandelwal, Priyanka and Meena, Jitendra and Geetha, Thenral S and Faruq, Mohammed and Hari, Pankaj and Sinha, Aditi and Bagga, Arvind},
title = {Spectrum of Alport syndrome in an Indian cohort},
journal = {Pediatric Nephrology},
year = {2025},
volume = {40},
number = {2},
pages = {393--405},
doi = {10.1007/s00467-024-06507-1}
}
EUVIMED